Monday, October 05, 2026

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Pfizer, Merck, Sanofi, GSK Will Continue to Dominate the Vaccine Market

Pfizer, Merck, Sanofi, GSK Will Continue to Dominate the Vaccine Market

The monopoly that Pfizer Inc., Merck & Co. Inc., Sanofi and GlaxoSmithKline plc (GSK) have on the vaccine market is unlikely to be broken, according to Jeffrey Holford, an equity analyst at global investment banking firm Jefferies. That market is projected to grow from $28.3 billion in 2015 to $72.5 billion in 2024. The four companies…

Takeda To Build Dengue Vaccine Manufacturing Plant in Germany

Takeda To Build Dengue Vaccine Manufacturing Plant in Germany

Headquartered in Japan, Takeda Pharmaceutical Company Ltd. is the largest pharmaceutical company in Asia and is speeding up development of a vaccine for dengue fever—a mosquito-borne flavivirus disease. The Japanese drugmaker has initiated a 20,000 patient based Phase 3 study in Asia and Latin America to test its…

CDC’s Rasmussen Paper on Zika and Microcephaly: Poor Case for ‘Smoking Gun’

CDC’s Rasmussen Paper on Zika and Microcephaly: Poor Case for ‘Smoking Gun’

History is filled with watershed moments which radically alter the way something is viewed and, thus, significantly influence the progression of future events. With regard to the way the mainstream medical community, public health officials, political leaders, and the general public in the United States have come to view the Zika virus and its relationship…

Joseph Mercola, DO on the Decline of Mercury and Increase of Aluminum in Vaccines

Joseph Mercola, DO on the Decline of Mercury and Increase of Aluminum in Vaccines

Mercury (thimerosal) exposure has declined significantly since it was eliminated from the single-dose vials of most childhood vaccines, yet autism rates have continued to skyrocket. This has led many to assume that mercury isn’t a problem, and anyone questioning the safety of vaccines is considered to be a hysterical wingnut. However, while mercury use has […]

Major Clinical Study on HIV Vaccine Begins in South Africa

Major Clinical Study on HIV Vaccine Begins in South Africa

In South Africa, seven million people (one in every five) live with the Human Immunodeficiency Virus (HIV)—the virus that causes Acquired Immune Deficiency Syndrome (AIDS). Research in that country is proceeding on the development of an HIV vaccine that some believe may provide relief for those suffering from this disease.

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.